Phosphotyrosine interaction domain containing 1
Appearance
Phosphotyrosine interaction domain containing 1 is a protein that in humans is encoded by the PID1 gene. [5]
References
[edit]- ^ a b c GRCh38: Ensembl release 89: ENSG00000153823 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000045658 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: Phosphotyrosine interaction domain containing 1". Retrieved 2018-06-01.
Further reading
[edit]- Wang B, Zhang M, Ni YH, Liu F, Fan HQ, Fei L, Pan XQ, Guo M, Chen RH, Guo XR (September 2006). "Identification and characterization of NYGGF4, a novel gene containing a phosphotyrosine-binding (PTB) domain that stimulates 3T3-L1 preadipocytes proliferation". Gene. 379: 132–40. doi:10.1016/j.gene.2006.05.008. PMID 16815647.
- Caratù G, Allegra D, Bimonte M, Schiattarella GG, D'Ambrosio C, Scaloni A, Napolitano M, Russo T, Zambrano N (February 2007). "Identification of the ligands of protein interaction domains through a functional approach". Mol. Cell. Proteomics. 6 (2): 333–45. doi:10.1074/mcp.M600289-MCP200. PMID 17124247. S2CID 17726406.
- Zhang CM, Chen XH, Wang B, Liu F, Chi X, Tong ML, Ni YH, Chen RH, Guo XR (January 2009). "Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt". Acta Pharmacol. Sin. 30 (1): 120–4. doi:10.1038/aps.2008.9. PMC 4006536. PMID 19079291.
- Zhang CM, Qiu J, Chen XH, Wang B, Zhang M, Guo XR (October 2009). "[Effects of NYGGF4 gene over-expression on the insulin sensitivity and secretory function of adipocytes]". Zhongguo Dang Dai Er Ke Za Zhi (in Chinese). 11 (10): 846–9. PMID 19849947.
- Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, Franceschini N, van Durme YM, Chen TH, Barr RG, Schabath MB, Couper DJ, Brusselle GG, Psaty BM, van Duijn CM, Rotter JI, Uitterlinden AG, Hofman A, Punjabi NM, Rivadeneira F, Morrison AC, Enright PL, North KE, Heckbert SR, Lumley T, Stricker BH, O'Connor GT, London SJ (January 2010). "Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function". Nat. Genet. 42 (1): 45–52. doi:10.1038/ng.500. PMC 2832852. PMID 20010835.
- Zhao Y, Wang J, Cai Y, Chen X, Zhang C, Guo X (February 2010). "[Expression of the NYGGF4 gene during human preadipocyte differentiation and the regulative role of tumor necrosis factor-alpha]". Zhonghua Yi Xue Yi Chuan Xue Za Zhi (in Chinese). 27 (1): 69–72. doi:10.3760/cma.j.issn.1003-9406.2010.01.015 (inactive 1 November 2024). PMID 20140872.
{{cite journal}}
: CS1 maint: DOI inactive as of November 2024 (link) - Zhao Y, Zhang C, Chen X, Gao C, Ji C, Chen F, Zhu C, Zhu J, Wang J, Qian L, Guo X (July 2010). "Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytes". Mol. Cell. Biochem. 340 (1–2): 41–8. doi:10.1007/s11010-010-0398-5. PMID 20165904. S2CID 29953818.
- Qiu J, Wang YM, Shi CM, Yue HN, Qin ZY, Zhu GZ, Cao XG, Ji CB, Cui Y, Guo XR (December 2012). "NYGGF4 (PID1) effects on insulin resistance are reversed by metformin in 3T3-L1 adipocytes". J. Bioenerg. Biomembr. 44 (6): 665–71. doi:10.1007/s10863-012-9472-x. PMID 22968630. S2CID 22368210.